BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Pasithea Therapeutics (NASDAQ:KTTA)

1 post

Biotech NewsPasithea Therapeutics (KTTA) Just Raised $5 Million—Is This the Spark it Needed?

  • BioTech Health X
  • July 20, 2025
Pasithea Therapeutics Corp. (NASDAQ:KTTA) is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments for central…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • TransMedics (TMDX) Could Be the Tesla of Transplants — Here’s Why Investors Are Paying Attention
  • Astera Labs (ALAB) is Down from Highs — But Here’s Why It’s About to Rebound Hard
  • Wall Street Sees 75% Upside: Is Replimune (REPL) the Best Biotech Stock to Buy Now?
  • Smart Investors Are Loading Up on GlucoTrack (GCTK) Before Q3 Milestones
  • Pasithea Therapeutics (KTTA) Just Raised $5 Million—Is This the Spark it Needed?
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • July 21, 2025
    TransMedics (TMDX) Could Be the Tesla of Transplants — Here’s Why Investors Are Paying Attention
    • July 21, 2025
    Astera Labs (ALAB) is Down from Highs — But Here’s Why It’s About to Rebound Hard
    • July 21, 2025
    Wall Street Sees 75% Upside: Is Replimune (REPL) the Best Biotech Stock to Buy Now?
    • July 21, 2025
    Smart Investors Are Loading Up on GlucoTrack (GCTK) Before Q3 Milestones
    • July 20, 2025
    Pasithea Therapeutics (KTTA) Just Raised $5 Million—Is This the Spark it Needed?
Recent Posts
  • CNS Pharmaceuticals (CNSP) Might Be 2025’s Most Explosive Biotech Play
    • July 20, 2025
  • Nature’s Sunshine (NATR) is Crushing Expectations—Is a 2025 Rally Imminent?
    • July 20, 2025
  • The Honest Company (HNST) Could Be Wall Street’s Most Underrated Clean Brand Stock Right Now
    • July 20, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (255)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top